no statement of use filed
on 06 Nov 2023
Last Applicant/ Owned by
201 King of Prussia Road, Suite 501
Radnor
PA
19087
Serial Number
88729359 filed on 16th Dec 2019
Registration Number
N/A
Correspondent Address
Joshua M. Gerben, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature Read More
Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy
N/A
N/A
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research
N/A
N/A
Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting
N/A
N/A
No 88729359
No Service Mark
No 07768-0008
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
06th Nov 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
06th Nov 2023 | ABANDONMENT - NO USE STATEMENT FILED |
05th Apr 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
03rd Apr 2023 | SOU EXTENSION 4 GRANTED |
03rd Apr 2023 | SOU EXTENSION 4 FILED |
03rd Apr 2023 | SOU TEAS EXTENSION RECEIVED |
20th Sep 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
16th Sep 2022 | SOU EXTENSION 3 GRANTED |
16th Sep 2022 | SOU EXTENSION 3 FILED |
16th Sep 2022 | SOU TEAS EXTENSION RECEIVED |